Regulus Therapeutics Inc.Atualizado $RGLS break out pattern / low volume - swing idea
Possible break out soon.
Low Risk / Reward to 50 dma
Reason:
Stair stepping on daily making higher lows
Low volume
Indicator: RSI is at 45 and has been increasing (not overbought yet)
MACD still in negative so this might spike soon.
Recent offering in 2018 had created a sell off and currently accumulation has been steadily moving the price higher.
Higher Lows
Other reasons that looks promising:
New: Patent approval
finance.yahoo.com/news/regulus-announces-preliminary-results-planned-210500664.html
Insider buyers
finance.yahoo.com/news/know-regulus-therapeutics-inc-nasdaq-145651204.html
Trade Idea:
Swing: buy near 1.10-1.13 or within the black dash line
Daytrade: wait for break of 1.23 or safer 1.25 (watch for news or volume to enter as this has low volume)
Remember to:
Trade with a plan, set your stop loss, take profits at any spike above 8% (rinse and repeat)
Low Risk / Reward to 50 dma
Reason:
Stair stepping on daily making higher lows
Low volume
Indicator: RSI is at 45 and has been increasing (not overbought yet)
MACD still in negative so this might spike soon.
Recent offering in 2018 had created a sell off and currently accumulation has been steadily moving the price higher.
Higher Lows
Other reasons that looks promising:
New: Patent approval
finance.yahoo.com/news/regulus-announces-preliminary-results-planned-210500664.html
Insider buyers
finance.yahoo.com/news/know-regulus-therapeutics-inc-nasdaq-145651204.html
Trade Idea:
Swing: buy near 1.10-1.13 or within the black dash line
Daytrade: wait for break of 1.23 or safer 1.25 (watch for news or volume to enter as this has low volume)
Remember to:
Trade with a plan, set your stop loss, take profits at any spike above 8% (rinse and repeat)
Ordem cancelada
failed to hold within the black dotted line. No entry.Nota
The market is perking up SPY / IBBRGLS has potential to pop after recent RS so this will be on alert if it goes back to buy zone.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.